Andrew Alliance and Arcis Biotechnology today announced a co-marketing relationship for deploying protocols that automate sample preparation for nucleic acid analysis on Andrew Alliance platforms. Under the terms of the agreement, Andrew Alliance and Arcis will promote the use of Arcis reagents for DNA and RNA preparation in conjunction with Andrew Alliance platforms such as the Andrew+ Pipetting Robot and OneLab Software.
“We are excited
to announce this exciting relationship with Andrew Alliance,” said Arcis CEO Peter Whitehurst. “The Andrew+ robot combined with our Arcis reagents represent a hands-free solution for stabilizing and preparing samples for RNA or DNA analysis, especially in infectious disease detection workflows, where speed is a key requirement.”
The groundbreaking Andrew+ design benefits from 6 years of user feedback on the award-winning Andrew Pipetting Robot. Andrew+ offers fully automated pipetting, as well as more complex manipulations, using a wide range of DOMINO Accessories and Andrew Alliance ...
